Fintel reports that on January 28, 2026, Cantor Fitzgerald upgraded their outlook for Korro Bio (NasdaqCM:KRRO) from Neutral to Overweight. Analyst Price Forecast Suggests 292.31% Upside As of January ...

At Northwestern, excellence has always been measured by more than just wins and losses. The program’s identity has long been ...

One example I highly recommend focuses on the work, not the life, of its subject. This is an edition of the Books Briefing, ...

There is one major battle remaining for Michigan State football in its 2026 recruiting class. The Spartans are battling with ...